Published in Eur J Cancer on June 01, 2000
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer (2007) 3.16
CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci U S A (2003) 1.78
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol (2004) 1.75
CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer (2006) 1.41
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer Res (2007) 1.35
Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia (2004) 1.33
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer (2003) 1.33
P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones (2008) 1.01
Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol (2002) 0.99
Expression of e-cadherin in high-risk breast cancer. J Cancer Res Clin Oncol (2004) 0.90
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer (2010) 0.89
Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis (2014) 0.87
Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? Diagn Pathol (2006) 0.85
Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt. Clinics (Sao Paulo) (2011) 0.83
Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome. World J Surg Oncol (2008) 0.83
Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors. BMC Vet Res (2015) 0.77
CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. Oncol Lett (2016) 0.77
Four cases of cell cannibalism in highly malignant feline and canine tumors. Diagn Pathol (2015) 0.75
Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma. J Pathol Transl Med (2016) 0.75
Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas. Ir Vet J (2016) 0.75
Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis. Oncotarget (2017) 0.75
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res (1996) 2.43
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res (1995) 2.14
The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev (2005) 2.08
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res (1997) 2.03
Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control (2001) 1.82
A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol (2007) 1.80
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev (1997) 1.80
Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A (1988) 1.76
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet (1996) 1.75
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer (1999) 1.71
Epidemiology of breast cancer in families in Iceland. J Med Genet (1992) 1.36
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer (1998) 1.28
Mechanisms of macrophage activation. Clin Exp Immunol (1980) 1.25
The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells. Clin Exp Immunol (1976) 1.25
Non-specific recognition mechanisms by mononuclear phagocytes. Clin Exp Immunol (1977) 1.25
The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine (1998) 1.05
Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients. Hum Mutat (1998) 1.05
Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer (1995) 1.04
Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer (1999) 1.04
Familial non-medullary thyroid cancer in Iceland. J Med Genet (2001) 1.02
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer (2002) 1.00
Reproductive factors and breast cancer risk in Iceland. A second cohort study. Int J Cancer (1990) 0.97
The role of cell wall carbohydrates in binding of microorganisms to mouse peritoneal exudate macrophages. Acta Pathol Microbiol Scand B (1978) 0.97
Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control (2005) 0.96
Binding of microorganisms to the macrophage plasma membrane; effects of enzymes and periodate. Br J Exp Pathol (1978) 0.94
The effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequences. Int J Oncol (2000) 0.94
Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer (2001) 0.94
Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Anticancer Res (1997) 0.94
Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables. Anticancer Res (1999) 0.93
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol (2013) 0.93
Immature B cells in bone marrow express Fas/FasL. Scand J Immunol (2000) 0.92
Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences. Proc Natl Acad Sci U S A (1986) 0.91
Altered expression of HLA class I antigens in breast cancer: association with prognosis. Int J Cancer (2000) 0.90
Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995. J Med Genet (1999) 0.90
Drosophila homolog of the murine Int-1 protooncogene. Proc Natl Acad Sci U S A (1988) 0.89
Serum thyroglobulin as a risk factor for thyroid carcinoma. Acta Oncol (2000) 0.88
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells. Br J Cancer (2000) 0.88
Gene localization on sorted chromosomes: definitive evidence on the relative positioning of genes participating in the mouse plasmacytoma-associated typical translocation. Proc Natl Acad Sci U S A (1985) 0.87
Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia. Leuk Res (1988) 0.86
Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees. Genet Epidemiol (2000) 0.86
Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait. Clin Genet (1995) 0.84
Gastric carcinomas of intestinal type concur with distant changes in the gastric mucosa. A multicenter study in the Atlantic basin. Anticancer Res (2001) 0.84
Nucleotide sequence of the rat Bmyc gene. Oncogene (1989) 0.84
Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int J Cancer (1995) 0.83
Stimulation of phosphatidylinositol turnover in the macrophage plasma membrane: a possible mechanism for signal transmission. Immunology (1979) 0.83
Human interdigitating dendritic cells induce isotype switching and IL-13-dependent IgM production in CD40-activated naive B cells. J Immunol (2000) 0.83
Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer (1996) 0.82
Similarities and differences in the regulation of N-myc and c-myc genes in murine embryonal carcinoma cells. Exp Cell Res (1987) 0.82
High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Oncogene (1998) 0.82
Gastric glassy cells: a study of 3202 gastrectomy specimens from dwellers of the Atlantic and Pacific basins. J Environ Pathol Toxicol Oncol (2005) 0.81
Methods for chemical analysis of contaminated soil samples--tests of their reproducibility between Nordic laboratories. Talanta (1998) 0.81
Metanephric adenoma. Scand J Urol Nephrol (1999) 0.81
Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer (1995) 0.81
Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. Genomics (1991) 0.81
Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. Proc Natl Acad Sci U S A (2001) 0.81
High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res (1998) 0.81
Binding of mouse peritoneal macrophages to tumour cells by a "lectin-like" macrophage receptor. J Clin Lab Immunol (1979) 0.81
A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). Oncogene (1990) 0.80
Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2. Clin Exp Immunol (1999) 0.79
Rubella in Iceland. Acta Pathol Microbiol Scand B (1975) 0.79
Differences in c-myc and pvt-1 amplification in SEWA sarcoma sublines selected for adherent or non-adherent growth. Int J Cancer (1990) 0.79
Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3. Hum Genet (1995) 0.78
Rapid polarization of Th2 cells during induction of antigen-specific IgE antibodies in vitro. Clin Exp Allergy (2000) 0.78
Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis. Breast Cancer Res Treat (1987) 0.78
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. J Med Genet (2000) 0.78
Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer. Eur J Cancer (2000) 0.78
Effects of tenuiorin and methyl orsellinate from the lichen Peltigera leucophlebia on 5-/15-lipoxygenases and proliferation of malignant cell lines in vitro. Phytomedicine (2002) 0.77
Replication error in human breast cancer: comparison with clinical variables and family history of cancer. Oncol Rep (1999) 0.77
Thiol modification in H2O2- and thromboxane-induced vaso- and bronchoconstriction in rat perfused lung. J Appl Physiol (1985) (1991) 0.77
Characterization of specific IgE response in vitro against protein and drug allergens using atopic and normal donors. Allergy (2002) 0.77
Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization. Cancer Genet Cytogenet (1996) 0.77
Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization. Oncogene (1988) 0.77
Chromosomal assignment of five cancer-associated rat genes: two thyroid hormone receptor (ERBA) genes, two ERBB genes and the retinoblastoma gene. Oncogene (1991) 0.76
Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2. Eur J Cancer (1998) 0.76
Urinary system tumours in a family. Eur J Cancer (1993) 0.76
The first Icelandic family with X-linked agammaglobulinaemia: studies of genetic markers and immune function. Scand J Immunol (1990) 0.75
Isoenzyme pattern and subcellular localization of hexokinases in human breast cancer and nonpathological breast tissue. Int J Cancer (1984) 0.75
CD40 employs p38 MAP kinase in IgE isotype switching. Biochem Biophys Res Commun (2001) 0.75
Suppression of target cell proliferation by natural killer cells. Scand J Immunol (1990) 0.75
[Carcinoma of the colon in Iceland 1955-1989. A study on pathology.]. Laeknabladid (2001) 0.75
Flow cytometric DNA analysis of adenocarcinomas of the vermiform appendix. Brief report. APMIS (1993) 0.75
The most frequently lost allelic site in human renal cell carcinoma (D3F15S2) on the short arm of chromosome 3 has homologous sequences on rat chromosome 8. Cytogenet Cell Genet (1991) 0.75
Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas. APMIS (1992) 0.75
[Hepatocellular carcinoma in Iceland.]. Laeknabladid (2001) 0.75
Tumors in Iceland. 12. Malignant tumours of the corpus of the uterus. A histological classification, epidemiological considerations and survival. APMIS (1989) 0.75
c-myc activation in spontaneous rat immunocytomas containing a 6;7 chromosomal translocation. Curr Top Microbiol Immunol (1986) 0.75
[The effect of pregnancy on the survival of women diagnosed with breast cancer.]. Laeknabladid (2006) 0.75
Catabolite repressive effects of 5-thio-D-glucose on Saccharomyces cerevisiae. J Gen Microbiol (1986) 0.75
Tumours in Iceland. Hodgkin's disease and non-Hodgkin's malignant lymphomas. A histological classification and epidemiological considerations. Acta Pathol Microbiol Immunol Scand A (1987) 0.75
Loss of heterozygosity at chromosome 1p in human breast cancer. Int J Oncol (1996) 0.75
A comparison of cytogenetic studies and flow cytometry in breast carcinomas. Cytometry (1997) 0.75
Recombinant plasmid expressing the entire coding region of the Bmyc putative protein. J Clin Lab Immunol (1990) 0.75
[Liver metastases of unknown origin.]. Laeknabladid (2000) 0.75